Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 210 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Athyros, Vasilios G [Clear All Filters]
The Effect of Proprotein Convertase Subtilisin-Kexin Type 9 and its Inhibition on Glucose Metabolism and Cardiovascular Risk. We Should do Better the Second Time After Statins..
Curr Pharm Des. 23(10), 1477-1483.
(2017). Effect of quinapril or losartan alone and in combination on left ventricular systolic and diastolic functions in asymptomatic patients with diabetic autonomic neuropathy..
J Diabetes Complications. 20(1), 1-7.
(2006). Effect of rosuvastatin on non-alcoholic steatohepatitis in patients with metabolic syndrome and hypercholesterolaemia: a preliminary report..
Curr Vasc Pharmacol. 12(3), 505-11.
(2014). The effect of SGLT2 inhibitors on cardiovascular events and renal function..
Expert Rev Clin Pharmacol. 10(11), 1251-1261.
(2017). The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials..
Eur Heart J. 36(24), 1536-46.
(2015). Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with CHD and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study..
Nephrol Dial Transplant. 22(1), 118-27.
(2007). Effect of Statins on rates of Long-Term Cardiovascular Events and Restenosis Following Carotid Endarterectomy..
Curr Vasc Pharmacol.
(2014). The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes..
Lancet Diabetes Endocrinol. 2(5), 362-3.
(2014). Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients..
Am J Cardiol. 101(4), 483-5.
(2008). Effects of lipid-lowering agents on inflammation, haemostasis and blood pressure..
Curr Pharm Des. 20(40), 6306-13.
(2014). Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness..
J Am Soc Hypertens. 8(2), 74-82.
(2014). Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia..
Am J Cardiol. 101(11), 1679-80.
(2008). Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study..
Curr Med Res Opin. 24(6), 1593-9.
(2008).
(2020). Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance..
J Clin Lipidol. 6(1), 93.
(2012). Endocrine hypertension: diagnosis and management of a complex clinical entity..
Curr Vasc Pharmacol. 8(5), 646-60.
(2010). Endothelial function, arterial stiffness and lipid lowering drugs..
Expert Opin Ther Targets. 11(9), 1143-60.
(2007). Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?.
Expert Opin Ther Targets. 12(7), 809-20.
(2008). Evaluation of the incidence and risk factors for development of fenofibrate-associated nephrotoxicity..
J Clin Lipidol. 7(1), 88.
(2013). Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment..
Curr Vasc Pharmacol. 13(6), 788-800.
(2015). Exploring the Management of Statin Intolerant Patients: 2016 and Beyond..
Curr Vasc Pharmacol. 14(6), 523-533.
(2016). Fibrinogen, hematocrit, and platelets in mild kidney dysfunction and the role of uric acid: an Italian male population study..
Clin Appl Thromb Hemost. 18(1), 113-4.
(2012).
(2015).
Has the time come for a new definition of microalbuminuria?.
Curr Vasc Pharmacol. 6(2), 81-3.
(2008). High density lipoprotein cholesterol and statin trials..
Curr Med Chem. 15(22), 2265-70.
(2008).